Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | BACE1 | P56817 | 2/20 | 0.36 |
| ▸ | GPR3 | P46089 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | ELANE | P08246 | 1/20 | 0.35 |
| ▸ | AR | P10275 | 1/20 | 0.35 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.34 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.34 |
| ▸ | HMGCR | P04035 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.33 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | KIF11 | P52732 | 1/20 | 0.33 |
| ▸ | CCR4 | P51679 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29378537 | 1.00 | CA2 (0.39) | CA2BACE1GPR3ATMELANE | |
| SCHEMBL17516297 | 0.81 | ALDH1A1 (0.49) | CA2GPR3ARGABRA1GABRB2 | |
| SCHEMBL26523061 | 0.79 | CA2 (0.47) | CA2BACE1ATMELANEAR | |
| SCHEMBL15614881 | 0.79 | CA2 (0.38) | CA2BACE1ATMELANEAR | |
| SCHEMBL13666780 | 0.79 | PDE10A (0.39) | GPR3ATMELANEALDH1A1HMGCR | |
| SCHEMBL22768285 | 0.78 | HMGCR (0.41) | GPR3ATMELANEGABRA1GABRB2 | |
| SCHEMBL23919954 | 0.77 | HMGCR (0.46) | BACE1GPR3ATMELANEALDH1A1 | |
| SCHEMBL12403549 | 0.77 | RAB9A (0.45) | ARALDH1A1HPGDCYP1A2NPC1 | |
| SCHEMBL20047599 | 0.77 | CCR4 (0.39) | CA2GPR3ATMELANEGABRA1 | |
| SCHEMBL19285964 | 0.77 | CA2 (0.35) | CA2BACE1ATMELANEAR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118105531-A | Hydrocolloid dressing, arteriovenous internal fistula wound dressing and application thereof | 大连医科大学附属第二医院 | 2024-05-31 | — | — | CN | claimed |
| CN-111501204-B | Comfortable protective gloves and preparation method thereof | 陈美荷 | 2022-02-11 | — | — | CN | claimed |
| CN-109395155-B | Silver-containing medical hydrocolloid dressing and preparation method thereof | Henan Huibo Medical Co.,Ltd. (CN) | 2021-06-22 | — | — | CN | claimed |
| CN-111501204-A | Comfortable protective gloves and preparation method thereof | 陈美荷 | 2020-08-07 | — | — | CN | claimed |
| CN-110982453-A | Rubber type water-based pressure-sensitive adhesive and preparation method and application thereof | 无锡达美新材料有限公司 | 2020-04-10 | — | — | CN | claimed |
| CN-109395155-A | A kind of argentiferous medical use hydrocolloid dressing and preparation method thereof | 河南汇博医疗股份有限公司 | 2019-03-01 | — | — | CN | claimed |
| CN-108926428-A | Hydrocolloid applies core and preparation method thereof, bearing hydrocolloid dressing and application thereof | 河南汇博医疗股份有限公司 | 2018-12-04 | — | — | CN | claimed |
| CN-108186197-A | A kind of complex function dressing for preventing and treating pressure sore and preparation method thereof | 河南汇博医疗股份有限公司 | 2018-06-22 | — | — | CN | claimed |
| CN-118105531-A | Hydrocolloid dressing, arteriovenous internal fistula wound dressing and application thereof | 大连医科大学附属第二医院 | 2024-05-31 | — | — | CN | disclosed |
| US-11446389-B2 | Maytansinoid derivatives, conjugates thereof, and methods of use | REGENERON PHARMACEUTICALS, INC. (US) | 2022-09-20 | — | — | US | disclosed |
| US-20220259225-A1 | Maytansinoid Derivatives, Conjugates Thereof, and Methods of Use | REGENERON PHARMACEUTICALS, INC. | 2022-08-18 | — | — | US | disclosed |
| CN-111501204-B | Comfortable protective gloves and preparation method thereof | 陈美荷 | 2022-02-11 | — | — | CN | disclosed |
| CN-110982453-B | Rubber type water-based pressure-sensitive adhesive and preparation method and application thereof | 广东创阳新材料科技有限公司 | 2021-08-10 | — | — | CN | disclosed |
| CN-108926428-B | Hydrocolloid dressing core and preparation method thereof, hydrocolloid dressing and application thereof | 河南汇博医疗股份有限公司 | 2021-07-30 | — | — | CN | disclosed |
| US-5868913-A | COATING BY PHYSICAL VAPOR DEPOSITION OF A MIXTURE OF RUTHENIUM OXIDE, AND AT LEAST ONE NON-NOBLE METAL OXIDE IN A SYSTEM CHARGED WITH OXYGEN AND HEAT TREATING THE COATED SUBSTRATE; IMPROVED DURABILITY ANODE FOR ELECTROLYTIC CELL | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1999-02-09 | — | — | US | disclosed |
| EP-0724656-A1 | ELECTRODE AND PREPARATION THEREOF | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1996-08-07 | — | — | EP | disclosed |
| WO-1995005499-A1 | ELECTRODE AND PREPARATION THEREOF | IMPERIAL CHEMICAL INDUSTRIES (GB) | 1995-02-23 | — | — | WO | disclosed |
| US-4975272-A | A MIXTURE OF SUNSCREEN AND AN ESTERIFIED, OIL-SOLUBLE, PHENOLIC LATENT OXIDATION INHIBITOR | VOYT WALTER F (US) | 1990-12-04 | — | — | US | disclosed |
| EP-0100793-B1 | AQUEOUS DISPERSIONS COMPRISING COLLOIDAL SIZED PARTICLES OF A POLYMER AND AN ADDITIVE AND A METHOD FOR THEIR PREPARATION | THE DOW CHEMICAL COMPANY (US) | 1986-10-15 | — | — | EP | disclosed |
| EP-0100793-A1 | Aqueous dispersions comprising colloidal sized particles of a polymer and an additive and a method for their preparation | THE DOW CHEMICAL COMPANY (US) | 1984-02-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11446389-B2 | Maytansinoid derivatives, conjugates thereof, and methods of use | HNMT, SLC10A1, SLC10A2 | CA2 3463/4885BACE1 2766/4885GPR3 1051/4885 |
| US-20220259225-A1 | Maytansinoid Derivatives, Conjugates Thereof, and Methods of Use | SLC10A1, HNMT, OGFR | CA2 3421/4885BACE1 2920/4885GPR3 1159/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.